Drug Shortage Report for JAMP-TOBRAMYCIN
| Report ID | 4845 |
| Drug Identification Number | 02420287 |
| Brand name | JAMP-TOBRAMYCIN |
| Common or Proper name | Tobramycin |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | TOBRAMYCIN |
| Strength(s) | 40MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 10x2 |
| ATC code | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2016-09-21 |
| Estimated end date | 2020-12-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2018-12-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2018-12-19 | French | Compare |
| v11 | 2018-12-19 | English | Compare |
| v10 | 2018-10-15 | French | Compare |
| v9 | 2018-10-15 | English | Compare |
| v8 | 2017-11-21 | French | Compare |
| v7 | 2017-11-21 | English | Compare |
| v6 | 2017-06-09 | French | Compare |
| v5 | 2017-06-09 | English | Compare |
| v4 | 2017-04-12 | French | Compare |
| v3 | 2017-04-12 | English | Compare |
| v2 | 2017-03-30 | French | Compare |
| v1 | 2017-03-30 | English | Compare |
Showing 1 to 12 of 12